Dadaos

Dadaos v. Allergan, Inc.

Good Law
United States District Court, Northern District of CaliforniaMay 3, 20223:22-cv-02394California340 words

Opinion

Trial Court Opinion

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: ALLERGAN BIOCELL TEXTURED BREAST

IMPLANT PRODUCTS LIABILITY LITIGATION MDL No. 2921

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO —40)

On December 18, 2019, the Panel transferred 4 civil action(s) to the United States District Court for the District of New Jersey for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 412 F.Supp.3d 1361 (J.P.M.L. 2019). Since that time, 133 additional action(s) have been transferred to the District of New Jersey. With the consent of that court, all such actions have been assigned to the Honorable Brian R. Martinotti. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the District of New Jersey and assigned to Judge Martinotti. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the District of New Jersey for the reasons stated in the order of December 18, 2019, and, with the…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.